From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis (Q38162082)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis |
scientific article |
Statements
1 reference
From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis (English)
1 reference
Kiran Motaparthi
1 reference
Vladimir Stanisic
1 reference
Abby S Van Voorhees
1 reference
Mark G Lebwohl
1 reference
Sylvia Hsu
1 reference
Medical Board of the National Psoriasis Foundation
1 reference
9 November 2013
1 reference
1 reference
70
1 reference
1
1 reference
178-186
1 reference
Identifiers
1 reference
1 reference